Ovarian tissue cryopreservation is an effective method for protecting against infertility as well as preservating endangered animal species. The technique is particularly sought after as a strategy against ovarian failure caused by aggressive chemotherapy in young women with cancer. There are two uses for cryopreserved ovarian tissues after thawing: grafting and culture. Grafting carries the risk of reintroduction of disease. This article describes the status of ovarian cryopreservation in humans and the other animals and also details the successful birth of a pup from preantral follicle oocytes derived from a mouse cryopreserved ovary followed by in vitro growth, in vitro maturation and in vitro fertilization-embryo transfer (IVF-ET).
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 24 • No. 1